Jamieson is pleased to announce that it has advised the management team of Viroclinics Biosciences B.V. on the sale of the business from Summit Partners to Cerba HealthCare S.A.S.
Viroclinics, headquartered in Rotterdam, Netherlands, is a leading diagnostic and clinical trial operation service company supporting clinical and preclinical studies for drug and vaccine development for prevention and treatment of virus infections. Viroclinics is a preferred virology testing laboratory for several of the global top-10 Biopharmaceutical companies.
Stuart Coventry, Gus Gayford & James Bezuidenhout advised the Viroclinics management team on the transaction.
